Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREINSUT: Sunitinib in mRCC
NCT00930345Phase 4Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2008
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sunitinib in clear cell renal cell carcinoma (ccRCC), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2008; status: terminated.
02
Drugs
sunitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT00930345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930345.